Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
Public ClinicalTrials.gov record NCT02709538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel-Group Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of a Fixed Dose Combination GSP 301 Nasal Spray Compared With Two Placebo Nasal Spray Formulations in Subjects (Aged 12 Years and Older) With Perennial Allergic Rhinitis (PAR)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the long term safety and efficacy of GSP 301 NS compared to 2 placebo NS formulations for the treatment of perennial allergic rhinitis (subjects 12 years of age and older)
Study identification
- NCT ID
- NCT02709538
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 601 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2016 (Type not available)
- Primary completion
- Jul 2017 (Actual)
- Completion
- Jul 2017 (Actual)
- Last update posted
- Feb 26, 2020
2016 – 2017
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 2 | Hot Springs | Arkansas | — | — |
| Investigational Site 28 | Encinitas | California | — | — |
| Investigational Site 27 | San Diego | California | — | — |
| Investigational Site 29 | San Diego | California | — | — |
| Investigational Site 32 | Denver | Colorado | — | — |
| Investigational Site 26 | Aventura | Florida | — | — |
| Investigational Site 9 | Miami | Florida | — | — |
| Investigational Site 33 | Tallahassee | Florida | — | — |
| Investigational Site 11 | Stockbridge | Georgia | — | — |
| Investigational Site 4 | Louisville | Kentucky | — | — |
| Investigational Site 5 | Bethesda | Maryland | — | — |
| Investigational Site 15 | St Louis | Missouri | — | — |
| Investigational Site 30 | Bellevue | Nebraska | — | — |
| Investigational Site 19 | Skillman | New Jersey | — | — |
| Investigational Site 18 | Corning | New York | — | — |
| Investigational Site 7 | High Point | North Carolina | — | — |
| Investigational Site 21 | Raleigh | North Carolina | — | — |
| Investigational Site 16 | Sylvania | Ohio | — | — |
| Investigational Site 22 | Pittsburgh | Pennsylvania | — | — |
| Investigational Site 13 | Spartanburg | South Carolina | — | — |
| Investigational Site 23 | Austin | Texas | — | — |
| Investigational Site 24 | Austin | Texas | — | — |
| Investigational Site 3 | Austin | Texas | — | — |
| Investigational Site 31 | Dallas | Texas | — | — |
| Investigational Site 34 | El Paso | Texas | — | — |
| Investigational Site 6 | Kerrville | Texas | — | — |
| Investigational Site 14 | New Braunfels | Texas | — | — |
| Investigational Site 10 | San Antonio | Texas | — | — |
| Investigational Site 12 | San Antonio | Texas | — | — |
| Investigational Site 17 | San Antonio | Texas | — | — |
| Investigational Site 1 | San Antonio | Texas | — | — |
| Investigational Site 20 | San Antonio | Texas | — | — |
| Investigational Site 25 | Waco | Texas | — | — |
| Investigational Site 8 | Waco | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02709538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2020 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02709538 live on ClinicalTrials.gov.